Balanced news tone
News Sentiment
VENUSREM sentiment intelligence
Venus Remedies Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
19 relevant articles
News tone and price action are not far from neutral.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-3.2% over one week, +60.7% over four weeks, trend active, and materially above fair value.
VENUS REMEDIES Share Price Today Down 5%
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
86/100 classification
One-week reaction
-3.2%
Price reacting lower
Trend fit
Trend active
60.7% over four weeks
Fair value
272.2%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
13
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Equitymaster
Direct company coverage
VENUS REMEDIES Share Price Today Down 5%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 05:52
- Source
- Equitymaster
Business Standard
Direct company coverage
Venus Remedies receives Saudi FDA approval for Plerixafor
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 22 May 2026 07:00
- Source
- Business Standard
simplywall.st
Direct company coverage
Does Venus Remedies (NSE:VENUSREM) Deserve A Spot On Your Watchlist?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- simplywall.st
The Economic Times
Direct company coverage
Venus Remedies expands Latin America presence with Argentina nod for antibiotic
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- The Economic Times
scanx.trade
Direct company coverage
Venus Remedies Files Newspaper Notice on Special Window for Physical Share Transfers
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- scanx.trade
Business Standard
Direct company coverage
Stocks to buy: ABB India, Venus Remedies, Karnataka Bk are on analyst radar
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 12 Mar 2026 07:00
- Source
- Business Standard
The Economic Times
Direct company coverage
Mahamaya Steel Industries - GK Energy, Venus Remedies among 7 stocks flashing bullish signals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Dec 2025 08:00
- Source
- The Economic Times
simplywall.st
Direct company coverage
Further Upside For Venus Remedies Limited (NSE:VENUSREM) Shares Could Introduce Price Risks After 25% Bounce
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Nov 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Venus Remedies Limited (NSE:VENUSREM) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Nov 2025 08:00
- Source
- simplywall.st
HDFC Sky
Direct company coverage
Venus Remedies Q2 Profit Jumps 473%; Shares Price Surge 14%
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 11 Nov 2025 08:00
- Source
- HDFC Sky
Investing.com India
Direct company coverage
Ixigo And Venus Remedies Show Long-term Upside Potential: SEBI RA Gunjan Kumar By Stocktwits
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jun 2025 07:00
- Source
- Investing.com India
Business Standard
Direct company coverage
Venus Remedies shares climb 14% after US FDA grants QIDP status to VRP-034
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2025 07:00
- Source
- Business Standard
London Stock Exchange
Direct company coverage
Infex signs MET-X agreement with Venus Remedies - 09:30:00 25 Feb 2025 - News article
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Feb 2025 08:00
- Source
- London Stock Exchange
Business Standard
Direct company coverage
Venus Remedies to co-develop antibiotic resistance blocker with UK firm
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Feb 2025 08:00
- Source
- Business Standard
Equitypandit
Direct company coverage
Venus Remedies Shares Were Trading 3% High on Securing GMP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Dec 2024 08:00
- Source
- Equitypandit
Upstox
Direct company coverage
Venus Remedies bags oncology contract from Pan American Health Organization, shares up 5%
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Jun 2024 07:00
- Source
- Upstox
The Times of India
Direct company coverage
Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 16 Oct 2023 07:00
- Source
- The Times of India
Business Standard
Direct company coverage
Venus Remedies zooms 20%; gets nod for 6 chemotherapy drugs in Philippines
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Oct 2023 07:00
- Source
- Business Standard
Upstox
Direct company coverage
VENUS REMEDIES LIMITED Share Price Today - Live VENUSREM Stock Price for NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Oct 2021 16:50
- Source
- Upstox